Furthermore, DPSC-CM decreased p-ERK (P44/42) to ERK (P44/42) ratio and significantly increased p- JNK/SAPK to JNK/SAPK ratio of MAPKinase pathways in CRC cells compared with the untreated control group. This evidence concerns the gene MAPK9 and colorectal carcinoma.